Jianqin Lu

机构：University of Arizona, Arizona Science Center, Guangzhou Women and Children Medical Center, Arizona Oncology, University of Montana, Guangzhou Medical University · ORCID：0000-0002-5877-619X

发表论文 90 篇 · 总被引 2989 次 · h-index 28

代表论文

• Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs (2024 · Journal of Medicinal Chemistry · 被引 33)
• Size-transformable nanotherapeutics for cancer therapy (2024 · Acta Pharmaceutica Sinica B · 被引 17)
• Biomimetic liposomes in drug delivery: from design mechanisms to applications (2025 · Chemical Society Reviews · 被引 16)
• A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer (2025 · Nature Cancer · 被引 13)
• Liposome‐Enabled Nanomaterials for Muscle Regeneration (2025 · Small Methods · 被引 10)
• Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32 (2025 · Acta Biomaterialia · 被引 6)